Evidence map›Paper›PMID 31852791›Full record

ArticleJournal of virology2020

Broad and Dynamic Diversification of Infectious Hepatitis C Virus in a Cell Culture Environment.

Isabel Gallego, María Eugenia Soria, Carlos García-Crespo, Qian Chen, Patricia Martínez-Barragán, Soumaya Khalfaoui, Brenda Martínez-González, Irene Sanchez-Martin, Inés Palacios-Blanco, Ana Isabel de Ávila and 8 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Viruses in astrobiology.Frontiers in microbiology · 2022
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 1 country.

Isabel Gallego *Centro de Biología Molecular "Severo Ochoa" (CBMSO, CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
María Eugenia Soria *Centro de Biología Molecular "Severo Ochoa" (CBMSO, CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
Carlos García-CrespoCentro de Biología Molecular "Severo Ochoa" (CBMSO, CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
Qian ChenCentro de Biología Molecular "Severo Ochoa" (CBMSO, CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
Patricia Martínez-BarragánCentro de Biología Molecular "Severo Ochoa" (CBMSO, CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
Soumaya KhalfaouiCentro de Biología Molecular "Severo Ochoa" (CBMSO, CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
Brenda Martínez-GonzálezCentro de Biología Molecular "Severo Ochoa" (CBMSO, CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
Irene Sanchez-MartinCentro de Biología Molecular "Severo Ochoa" (CBMSO, CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
Inés Palacios-BlancoCentro de Biología Molecular "Severo Ochoa" (CBMSO, CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
Ana Isabel de ÁvilaCentro de Biología Molecular "Severo Ochoa" (CBMSO, CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
Damir García-CehicCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain.
Juan Ignacio EstebanCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain.
Jordi GómezCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain.
Carlos BrionesCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain.
Josep GregoriCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain.
Josep QuerCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain.
Celia PeralesCentro de Biología Molecular "Severo Ochoa" (CBMSO, CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain cperales@cbm.csic.es edomingo@cbm.csic.es.
Esteban DomingoCentro de Biología Molecular "Severo Ochoa" (CBMSO, CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain cperales@cbm.csic.es edomingo@cbm.csic.es.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ESCentro de Biología Molecular Severo Ochoa · ESUniversidad Autónoma de Madrid · ESUniversitat Autònoma de Barcelona · ESCentro de Astrobiología · ESConsejo Superior de Investigaciones Científicas · ESRoche (Spain) · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies documented that long-term hepatitis C virus (HCV) replication in human hepatoma Huh-7.5 cells resulted in viral fitness gain, expansion of the mutant spectrum, and several phenotypic alterations. In the present work, we show that mutational waves (changes in frequency of individual mutations) occurred continuously and became more prominent as the virus gained fitness. They were accompanied by an increasing proportion of heterogeneous genomic sites that affected 1 position in the initial HCV population and 19 and 69 positions at passages 100 and 200, respectively. Analysis of biological clones of HCV showed that these dynamic events affected infectious genomes, since part of the fluctuating mutations became incorporated into viable genomes. While 17 mutations were scored in 3 biological clones isolated from the initial population, the number reached 72 in 3 biological clones from the population at passage 200. Biological clones differed in their responses to antiviral inhibitors, indicating a phenotypic impact of viral dynamics. Thus, HCV adaptation to a specific constant environment (cell culture without external influences) broadens the mutant repertoire and does not focus the population toward a limited number of dominant genomes. A retrospective examination of mutant spectra of foot-and-mouth disease virus passaged in cell cultures suggests a parallel behavior here described for HCV. We propose that virus diversification in a constant environment has its basis in the availability of multiple alternative mutational pathways for fitness gain. This mechanism of broad diversification should also apply to other replicative systems characterized by high mutation rates and large population sizes.

Indexed as

Adaptation, PhysiologicalCell Culture TechniquesMutationVirus ReplicationCell Line, TumorHepacivirusHumansadaptationmutant spectrummutational wavesRNA virus evolutionsequence spaceviral quasispecies

Identifiers

PMID31852791
PMCPMC7158725
OpenAlexW2996286854

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.